Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: Inj triamcinolone acetonide: Inj triamcinolone acetonide to be injected at 0
6 weeks.
Intervention2: injection platelet rich plasma: Injection platelet rich plasma given 3weekly for 3 doses in the treatment of localized alopecia areata of the scalp (aged 18-60 years)
Control I
Sponsors
DR BSA MEDICAL COLLEGE
Eligibility
Inclusion criteria
Inclusion criteria: Clinically diagnosed cases of alopecia areata of scalp aged 18-60 years with • Patients with 1-5 patches of hair loss. • Patient who gives consent for the study
Exclusion criteria
Exclusion criteria: Patients with alopecia totalis,alopecia universalis or Ophiasis. 1.Patient with history of diabetes,hypertension,thromboembolism,bleeding disorders,abnormal coagulogram, patient already on steroid therapy,keloidal tendencyetc. 2.Pregnant or lactating female. 3.Patient with any active skin infectionat the site of hair loss. 4.Patient who has taken topical or intralesional treatment within last 1 month and oral treatment within last 3 months for alopecia areata.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the SALT Score to prove efficacy of platelet rich plasma vs.intralesional triamcinolone acetonide (10mg/ml) given 3weekly for 3 doses in the treatment of localized alopecia areata of the scalp (aged 18-60 years) as assessed by mean SALT scoring.Timepoint: 3,6 and 9 weeks follow up | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.To compare the efficacy as per Hair Regrowth Grade Scale (HRG) at 3, 6 & 9 weeks between two groups. 2.To compare VAS for pain due to intralesional injection between the two groups. 3.To compare the patient satisfaction score between two groups. 4.To compare the relapse rates at 18 weeks in both groups. 5.To compare the side effect profile between two groups.Timepoint: 0,3,6,9,18 WEEKS | — |
Countries
India
Contacts
Public ContactYashika Sethi
Dr. BSA Hospital
Outcome results
None listed